Company Information
Industry 批发和零售业
Company Introduction 瑞康医药股份有限公司是一家高成长性的、中型的药品直销服务商,是一家医药商业企业.公司是以山东省为目标市场、以规模以上医院及基础医疗市场的直接销售为主营业务.2008年7月17日,公司被山东省食品药品监督管理局批准为药品委托配送业务试点单位;2009年11月20日,被山东省食品药品监督管理局列入山东省第一批药品现代物流试点企业.在中国医药商业协会公布的2009年全国医药商业百强排名中进入全国50强,销售收入位列第38位.按此商业排名,公司在山东省医药商业销售规模位列第三位,同时,公司在医院直配市场处于山东省医药商业领先地位。
Main Business 药品直销服务商。
Legal Representative 韩旭
Top Executives
董事长:韩旭
董事:张寿凯,李喆,吴丽艳,韩春林,杨博
独立董事:王吉法,柳喜军,孙考祥
Top 5 Shareholder
Shareholder name Nature Holding Date
张仁华流通A股13.39%31/03/2024
韩旭限售股+流通A股12.33%31/03/2024
荆州招商慧泽医药投资合伙企业(有限合伙)流通A股5.00%31/03/2024
瑞康医药集团股份有限公司-2022年员工持股计划流通A股2.02%31/03/2024
江阴毅达高新股权投资合伙企业(有限合伙)流通A股1.97%31/03/2024
Company Secretary 李喆
Solicitors 北京市天元律师事务所
Auditors 北京天圆全会计师事务所(特殊普通合伙)
Tel No 0535-6737695
Fax No 0535-6737695
Website www.realcan.cn
Email stock@realcan.cn;dongmi@realcan.cn
Company Address
Register: 山东省烟台市芝罘区凤鸣路103号13号楼
Office: 山东省烟台市芝罘区凤鸣路103号13号楼
Listing Date 10/06/2011
Shares Capital
Shares Capital: 1,504,710,471
Total A Share: 1,504,710,471
Listed A Share: 1,364,091,548
Non-tradable A Share: 140,618,923
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.014
DPS(RMB)* ¥ 0.013
NBV Per Share(RMB)* ¥ 3.620
Market Capitalization(RMB) 3.533B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.